CELESTIA NIELSEN: Open Payments
NPI 1093349391 · LIBERTYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,133 in 80 payments from 11 companies in 2025. Trend: 2023 $521 · 2024 $1,842 · 2025 $3,133
Food & beverage: $2,465Consulting: $630Travel & lodging: $38
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 20 | $1,568 |
| AstraZeneca Pharmaceuticals LP | 20 | $777 |
| Regeneron Healthcare Solutions, Inc. | 5 | $176 |
| GlaxoSmithKline, LLC. | 9 | $168 |
| Philips North America LLC | 12 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $101 |
| Amgen Inc. | 3 | $65 |
| Viatris Specialty LLC | 3 | $51 |
| Grifols USA, LLC | 2 | $50 |
| Abbott Laboratories | 1 | $23 |
Products named: DUPIXENT, BREZTRI, TEZSPIRE, AIRSUPRA, FASENRA, Vest Therapy Und, NUCALA, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
